Vagus Nerve Stimulation for Refractory Seizures in Children with Hypoxic Brain Damage
Introduction to VNS Therapy
- The FDA approved VNS in 1997 specifically for patients with refractory epilepsy who have failed to control seizures with antiepileptic medications alone, typically after trying two or more anti-epileptic drugs 1
- The American Academy of Neurology confirms this indication for patients with refractory epilepsy who have failed pharmacologic solutions 2, 1
Efficacy and Safety of VNS
- Approximately 51% of patients experience ≥50% reduction in seizure frequency with VNS 1
- Continuous intermittent stimulation provides preventive seizure control 1
- Closed-loop stimulation triggered by ictal tachycardia can abort seizures early, reducing seizure duration from ~30 seconds to ~5 seconds when delivered within 3 seconds of onset 3, 4